Skip to main content

Thrivent Financial for Lutherans

Position in NBIX — Neurocrine Biosciences Inc

CIK 314984 Minneapolis, MN

Position in NBIX

as of Mar 31, 2026 · filed May 1, 2026
Position Value
$12,710,933
-$98,868 QoQ
Shares Held
96,485
+6.8% QoQ
Ownership
0.096%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Thrivent Financial for Lutherans holds $123,026,116 across 22 Drug Manufacturers - Specialty & Generic names. NBIX ranks #3 (10.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 NBIX
Neurocrine Biosciences Inc
This page
96,485 $12,710,933

All Filings in NBIX

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $12,710,933 96,485
2025-12-31 $12,809,801 90,318
2025-09-30 $80,267,178 571,785
2025-06-30 $98,955,611 787,299
2025-03-31 $97,196,938 878,815
2024-12-31 $100,705,877 737,772
2024-09-30 $2,972,906 25,802
2024-06-30 $6,412,255 46,577
2024-03-31 $3,439,173 24,936
2023-12-31 $3,234,049 24,545
2023-09-30 $2,750,737 24,451
2023-06-30 $2,374,945 25,185
2023-03-31 $2,580,097 25,490
2022-12-31 $3,615,687 30,272
2022-09-30 $2,688,493 25,313
2022-06-30 $2,444,311 25,075
2022-03-31 $2,324,062 24,790
2021-12-31 $2,130,442 25,014
2021-09-30 $2,372,717 24,739
2021-06-30 $2,442,634 25,099
2021-03-31 $2,428,818 24,975
2020-09-30 $3,425,699 35,625
2020-06-30 $27,819,050 228,025
2020-03-31 $19,642,522 226,950